Home/Filings/4/0000899243-20-031483

4//SEC Filing

COLUMN GROUP III, LP 4

Accession 0000899243-20-031483

CIK 0001628171other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 7:06 PM ET

Size

30.3 KB

Accession

0000899243-20-031483

Insider Transaction Report

Form 4

Period: 2020-11-16

Revolution Medicines, Inc.RVMD

PONOI CAPITAL, LP

10% Owner

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)
Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

Ponoi Capital II, LP

10% Owner

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

Ponoi II Management, LLC

10% OwnerOther

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

COLUMN GROUP III, LP

10% Owner

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

COLUMN GROUP III GP, LP

10% OwnerOther

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

GOEDDEL DAVID V

10% OwnerOther

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

Kutzkey Tim

10% OwnerOther

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

COLUMN GROUP III-A, LP

10% Owner

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total
Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

Ponoi Management, LLC

10% OwnerOther

Transactions

Sale
Common Stock
2020-11-16$36.40/sh−1,075,133$39,134,841→ 2,429,180 total(indirect: See Footnote)
Sale
Common Stock
2020-11-16$36.40/sh−952,023$34,653,637→ 2,151,026 total

Holdings

Common Stock
(indirect: See Footnote)
685,011
Common Stock
(indirect: See Footnote)
685,011

Footnotes (4)

[F1]The securities are directly held by The Column Group III, LP ("TCG III LP"). The Column Group III GP, LP ("TCG III GP") is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are David Goeddel, Peter Svennilson, a member of the Issuer's board of directors, and Tim Kutzkey (collectively, the "Managing Partners"). The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares
[F2]The securities are directly held by The Column Group III-A, LP ("TCG III-A LP"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares
[F3]The securities are directly held by Ponoi Capital, LP ("Ponoi LP"). Ponoi Management, LLC ("Ponoi LLC") is the general partner of Ponoi LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of Ponoi II LLC are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. Ponoi LLC and the each of the Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares
[F4]The securities are directly held by Ponoi Capital II, LP ("Ponoi II LP"). Ponoi II Management, LLC ("Ponoi II LLC") is the general partner of Ponoi II LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of Ponoi II LLC are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. Ponoi II LLC and the each of the Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Documents

2 files

Issuer

Revolution Medicines, Inc.

CIK 0001628171

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001668159

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 7:06 PM ET
Size: 30.3 KB

View on SEC.gov